Drugs / Glycerin trinitrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT06823843 | Jul → Sep 2024 | coronary artery disorder | VZW Cardiovascular Research Center Aalst | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT00927849 Comparator | Sep 2002 → Apr 2008 | rectal disorder | Mansoura University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glycerin trinitrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06823843 ↗ |
| Known as | GTN | “Glycerin trinitrate (GTN)” NCT06823843 ↗1“Glycerin trinitrate (GTN)” NCT00927849 ↗ |
| Route | Topical | “apply the GTN ointment 0.2 % twice a day to the edge and just inside the anal canal” NCT00927849 ↗ |